Breaking News Instant updates and real-time market news.

GWPH

GW Pharmaceuticals

$133.10

-0.35 (-0.26%)

10:53
10/07/16
10/07
10:53
10/07/16
10:53

Goldman says marijuana-derived drug maker GW Pharma 'set to fly high'

In a note to investors this morning, Goldman Sachs analyst Salveen Richter initiated GW Pharmaceuticals (GWPH) with a Buy rating, as he expects a "solid" launch trajectory for the company's lead asset Epidiolex. Earlier this week, his peer at Leerink resumed coverage of the stock with a Buy-equivalent rating, citing also the potential uptake trajectory of its investigational drug. BACKGROUND: GW Pharmaceuticals is a pre-commercial-stage biopharmaceutical company focused on cannabis-based therapies in central nervous system disorders. Its lead asset is Epidiolex for Dravet Syndrome and Lennox-Gastaut Syndrome, two severe orphan epilepsies. 'SOLID' LAUNCH, UPCOMING CATALYSTS: Goldman Sachs' Richter initiated coverage of GW Pharmaceuticals with a Buy rating, saying it is "set to fly high." The analyst told investors that he expects a "solid" launch trajectory for the company's lead asset Epidiolex, and is modeling $1.6B in world-wide sales. Further, Richter sees GW Pharmaceuticals' shares trading higher on upcoming pipeline catalysts, including the publication of Epidiolex Phase 3 study data in Dravet syndrome in a top-tier medical journal in the fourth quarter, the American Epilepsy Society meeting, and the initiation of an Epidiolex Phase 3 study in infantile spasms in the fourth quarter, among a number of other events. GW Pharmaceuticals should submit the U.S. regulatory filing for Epidiolex in Dravet Syndrome and Lennox-Gastaut Syndrome in the first half of 2017, he noted, adding that he expects U.S. and EU launches in the second or third quarter of 2018. The analyst has a $189 price target on the shares. UPTAKE DRUG TRAJECTORY: On Tuesday, Leerink analyst Paul Matteis resumed coverage of GW Pharmaceuticals with an Outperform rating and $162 price target, saying he is "highly positive" on the potential uptake trajectory of Epidiolex, now that its approval appears mostly de-risked after three successful Phase 3 trials in Dravet Syndrome and Lennox Gastaut. Moreover, the analyst sees multiple points of optimism regarding a GW Pharmaceuticals-led global launch, including strong clinical profile and "hype" surrounding Epidiolex, significant level of unmet medical need in Dravet Syndrome and Lennox Gastaut and refractory seizures, a small subset of core prescribers, and the experience of CCO Julian Gangoli. PRICE ACTION: In morning trading, shares of GW Pharmaceuticals have slipped about 1% to $131.90.

GWPH GW Pharmaceuticals
$133.10

-0.35 (-0.26%)

10/04/16
LEER
10/04/16
INITIATION
Target $162
LEER
Outperform
GW Pharmaceuticals reinstated with an Outperform at Leerink
Leerink analyst Paul Matteis resumed coverage of GW Pharmaceuticals with an Outperform rating and $162 price target.
10/07/16
GSCO
10/07/16
INITIATION
Target $189
GSCO
Buy
GW Pharmaceuticals initiated with a Buy at Goldman
Goldman analyst Salveen Richter initiated GW Pharmaceuticals with a Buy saying he expects a solid launch trajectory for lead assets Epidiolex for Dravet Syndrome and Lennox-Gastaut Syndrome, two severe orphan epilepsies, and is modeling $1.6B in world-wide sales. Richter has a $189 price target on shares based on a blend of discounted cash flow for $161 per shares and M&A value of $349 per share.
10/07/16
GSCO
10/07/16
NO CHANGE
GSCO
Smid-cap Biotech sector upgraded to Attractive from Neutral at Goldman
Goldman analyst Salveen Richter upgraded the Smid-cap biotechnology to Attractive and said he favors and companies with near-term pipeline data or regulatory events where he has conviction.Names he recommends are Buy rated BioMarin (BMRN), bluebird bio (BLUE), GW Pharma (GWPH), Incyte (INCY), Kite (KITE), and Sage (SAGE).
10/07/16
10/07/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Zillow (ZG, Z) initiated with a Buy at Needham. 2. AMD (AMD) initiated with an Equal Weight at Barclays. 3. Aflac (AFL) was initiated with an Underperform at Credit Suisse while the firm also initiated Prudential (PRU) and Assurant (AIZ) with a Neutral. 4. Fifth Third (FITB) initiated with a Neutral at Wedbush. 5. GW Pharmaceuticals (GWPH) initiated with a Buy at Goldman. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

LOGI

Logitech

$37.02

0.46 (1.26%)

17:02
06/28/17
06/28
17:02
06/28/17
17:02
Hot Stocks
Logitech nominates to new directors, proposes 10% dividend increase »

Logitech announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

BLCM

Bellicum Pharmaceuticals

$13.32

0.18 (1.37%)

17:00
06/28/17
06/28
17:00
06/28/17
17:00
Syndicate
Breaking Syndicate news story on Bellicum Pharmaceuticals »

Bellicum files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

XLF

Financial Select Sector

$24.52

0.38 (1.57%)

17:00
06/28/17
06/28
17:00
06/28/17
17:00
Technical Analysis
Technical View: Financial Select Sector rises in extended trading »

The Financial Select…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$65.18

0.95 (1.48%)

16:58
06/28/17
06/28
16:58
06/28/17
16:58
Technical Analysis
Technical View: Citi rises after hours »

In the extended session…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 14

    Jul

  • 20

    Jul

  • 25

    Jul

BAC

Bank of America

$23.88

0.61 (2.62%)

16:54
06/28/17
06/28
16:54
06/28/17
16:54
Hot Stocks
Bank of America to boost quarterly dividend 60%, authorizes $12B share buyback »

Bank of America announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNSL

Consolidated Communications

$21.27

0.53 (2.56%)

, FRP

FairPoint

$15.50

0.5 (3.33%)

16:54
06/28/17
06/28
16:54
06/28/17
16:54
Hot Stocks
Consolidated Communications-FairPoint merger secures regulatory approvals »

Consolidated…

CNSL

Consolidated Communications

$21.27

0.53 (2.56%)

FRP

FairPoint

$15.50

0.5 (3.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.24

2.66 (1.77%)

16:54
06/28/17
06/28
16:54
06/28/17
16:54
Periodicals
Facebook creating ad targeting for families, Axios reports »

Facebook is creating new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

NTRS

Northern Trust

$96.66

1.24 (1.30%)

16:52
06/28/17
06/28
16:52
06/28/17
16:52
Hot Stocks
Northern Trust to increase dividend to 42c per share, buy back $750M in stock »

Northern Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

SBOT

Stellar Biotechnologies

$1.23

-0.05 (-3.91%)

16:51
06/28/17
06/28
16:51
06/28/17
16:51
Hot Stocks
Breaking Hot Stocks news story on Stellar Biotechnologies »

Frank R. Oakes reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMA

Comerica

$71.94

0.14 (0.19%)

16:51
06/28/17
06/28
16:51
06/28/17
16:51
Hot Stocks
Comerica plans to increase dividend 15%, buy back up to $605M of common stock »

Comerica announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$89.82

1.77 (2.01%)

16:50
06/28/17
06/28
16:50
06/28/17
16:50
Hot Stocks
JPMorgan to up quarterly dividend to 56c/share, authorizes $19.4B share buyback »

JPMorgan Chase & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jul

  • 12

    Oct

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

BBVA

Banco Bilbao

$8.54

0.16 (1.91%)

16:50
06/28/17
06/28
16:50
06/28/17
16:50
Hot Stocks
BBVA Compass receives no objection to its 2017 capital plan »

BBVA Compass Bancshares,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

ZION

Zions Bancorp

$42.97

0.43 (1.01%)

16:49
06/28/17
06/28
16:49
06/28/17
16:49
Hot Stocks
Zions to boost common dividend to 24c per share by 2Q18 »

The Board of Governors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNC

PNC Financial

$123.40

2.28 (1.88%)

16:48
06/28/17
06/28
16:48
06/28/17
16:48
Hot Stocks
PNC says proposed capital plans include 36% dividend hike, $2.7B in buybacks »

The PNC Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jul

MBUU

Malibu Boats

$25.75

0.28 (1.10%)

16:47
06/28/17
06/28
16:47
06/28/17
16:47
Hot Stocks
Malibu Boats to acquire Cobalt Boats for $130M »

Malibu Boats announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIT

CIT Group

$48.61

0.27 (0.56%)

16:47
06/28/17
06/28
16:47
06/28/17
16:47
Hot Stocks
CIT Group receives no objection to its 2017 capital plan »

CIT Group announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DFS

Discover

$61.88

0.81 (1.33%)

16:47
06/28/17
06/28
16:47
06/28/17
16:47
Hot Stocks
Discover to boost quarterly dividend to 35c per share, authorizes $2.23B buyback »

Discover Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

AMZN

Amazon.com

$990.33

13.55 (1.39%)

, WMT

Wal-Mart

$76.51

0.5 (0.66%)

16:46
06/28/17
06/28
16:46
06/28/17
16:46
Periodicals
Amazon holds first ever 'meet and greet' for sellers, Bloomberg says »

Amazon (AMZN) is holding…

AMZN

Amazon.com

$990.33

13.55 (1.39%)

WMT

Wal-Mart

$76.51

0.5 (0.66%)

EBAY

eBay

$35.31

0.4 (1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

STI

SunTrust

$56.09

0.88 (1.59%)

16:46
06/28/17
06/28
16:46
06/28/17
16:46
Hot Stocks
SunTrust boosts quarterly dividend 54%, authorizes $1.32B share buyback »

SunTrust Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

KEY

KeyCorp

$18.38

0.18 (0.99%)

16:44
06/28/17
06/28
16:44
06/28/17
16:44
Hot Stocks
KeyCorp to boost quarterly dividend to 10.5c per share, to repurchase $800M »

KeyCorp announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BK

BNY Mellon

$50.60

0.92 (1.85%)

16:43
06/28/17
06/28
16:43
06/28/17
16:43
Hot Stocks
BNY Mellon to raise dividend 24%, repurchase up to $3.1B of common stock »

BNY Mellon announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

CFG

Citizens Financial

$35.34

0.5 (1.44%)

16:42
06/28/17
06/28
16:42
06/28/17
16:42
Hot Stocks
Citizens Financial plans 18c per share quarterly dividends, $850M share buyback »

Citizens Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

FITB

Fifth Third

$25.49

0.4 (1.59%)

, VNTV

Vantiv

$63.47

1.09 (1.75%)

16:41
06/28/17
06/28
16:41
06/28/17
16:41
Hot Stocks
Fifth Third to raise dividend to 16c, repurchase $1.161B of common stock »

Fifth Third Bancorp…

FITB

Fifth Third

$25.49

0.4 (1.59%)

VNTV

Vantiv

$63.47

1.09 (1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

BBT

BB&T

$44.78

0.96 (2.19%)

16:41
06/28/17
06/28
16:41
06/28/17
16:41
Hot Stocks
BB&T says proposed capital plans include 10% dividend hike, $1.88B in buybacks »

BB&T announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 19

    Oct

MBUU

Malibu Boats

$25.75

0.28 (1.10%)

16:40
06/28/17
06/28
16:40
06/28/17
16:40
Hot Stocks
Breaking Hot Stocks news story on Malibu Boats »

Malibu Boats trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.